Literature DB >> 12435773

Human immunodeficiency virus type 1 Western blot: revised diagnostic criteria with fewer indeterminate results for epidemiological studies in Africa.

Cédric Mahé1, Pontiano Kaleebu, Amato Ojwiya, James A G Whitworth.   

Abstract

BACKGROUND: Western blot (WB) criteria in epidemiological studies in Africa exhibit an unacceptably high proportion of indeterminate results. New diagnostic criteria are urgently needed.
METHODS: From 1989 to 1998, WB confirmatory tests were performed after weakly positive or discordant results of two enzyme immunoassays in a large Ugandan population. Enzyme immunoassays (EIA) on new sera taken prospectively from the same individuals one year later were used to assess the human immunodeficiency virus (HIV) status of these people. A logistic model was used to determine which set of WB bands was the most predictive of HIV status. Diagnostic criteria were then established, based on the likely HIV status determined using the predictive values and the intensity of the bands.
RESULTS: Using 1109 WB tests, the best diagnostic criteria were based on only two bands (gp160 and p31). These criteria were validated on an independent sample of 587 WB tests, giving a high sensitivity and specificity (90.3% and 97.0%, respectively) and few indeterminate results (2.7%). These criteria classified correctly 96.3% of the sera.
CONCLUSION: Our diagnostic criteria gave far better results in our population than the existing published criteria. This suggests that new criteria could be developed to improve WB interpretation in African settings.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12435773     DOI: 10.1093/ije/31.5.985

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  6 in total

Review 1.  Frequency, causes, and new challenges of indeterminate results in Western blot confirmatory testing for antibodies to human immunodeficiency virus.

Authors:  Ming Guan
Journal:  Clin Vaccine Immunol       Date:  2007-04-04

2.  Performance of the Euroline Western blot assay in the detection of herpes simplex virus type 2 antibody in Uganda, China and the USA.

Authors:  J D Neal; A A R Tobian; O Laeyendecker; T D Ngo; A D Redd; S J Reynolds; R Ashley Morrow; J L Manucci; D Serwadda; R H Gray; T C Quinn
Journal:  Int J STD AIDS       Date:  2011-06       Impact factor: 1.359

3.  Performance characteristics of a new rapid immunochromatographic test for the detection of antibodies to human immunodeficiency virus (HIV) types 1 and 2.

Authors:  H Syed Iqbal; P Balakrishnan; K G Murugavel; Solomon Suniti
Journal:  J Clin Lab Anal       Date:  2008       Impact factor: 2.352

4.  Early detection of human immunodeficiency virus type 1-specific B-lymphocyte-derived antibodies in a high-risk population.

Authors:  Odd Odinsen; David Parker; Frans Radebe; Mikey Guness; David A Lewis
Journal:  Clin Vaccine Immunol       Date:  2009-05-27

5.  Cell Proteins Interacting with the Human Immunodeficiency Virus in Immunoblotting can be Detected by R5- or X4- Tropic Human Immunodeficiency Virus Particles.

Authors:  Zeina Soayfane; Bilal Houshaymi; Mamdouh H Kedees; Laurent Belec; Nadine Nasreddine
Journal:  Int J Appl Basic Med Res       Date:  2020-04-02

6.  Inaccurate diagnosis of HIV-1 group M and O is a key challenge for ongoing universal access to antiretroviral treatment and HIV prevention in Cameroon.

Authors:  Avelin F Aghokeng; Eitel Mpoudi-Ngole; Henriette Dimodi; Arrah Atem-Tambe; Marcel Tongo; Christelle Butel; Eric Delaporte; Martine Peeters
Journal:  PLoS One       Date:  2009-11-06       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.